HPV Self-Collection Program for Cervical Cancer Screening

This study is developing and testing an HPV (human papillomavirus) self-collection program to help women who are overdue for cervical cancer screening. The program aims to make screening easier by offering HPV self-collection kits that can be used at home or in the clinic, alongside the traditional Pap test. Researchers will create materials to explain HPV, cervical cancer, and how to use the self-collection kits. The main goal is to see how well these programs are put into practice in clinics over one year. You may be able to join if you are a woman or individual with a cervix, aged 25-65, and overdue for cervical cancer screening. The study plans to enroll 1000 participants.

Study design
This is an interventional study, meaning participants will receive a specific intervention. It aims to enroll 1000 participants.
What's involved
Participants would be offered an HPV self-collection option for cervical cancer screening, either by mail or in the clinic. They would also receive informational resources on how to complete the test.
Compensation
Not stated in the trial record.
Follow-up
The study measures how well the program is implemented at the clinic level for one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06674681

HPV Self-Collection Program

Recruiting
NAAges 25–65InterventionalHealth services
University of Utah
~1,000 participants
Updated 2026-02-20 on ClinicalTrials.gov
What's tested:HPV Self-Collection

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Clinic Level Implementation Rate
Measured over 1 year
HPV
1 sites across 1 states
Utah1
  • Deanna Kepka, PhD, MPH · PRINCIPAL_INVESTIGATOR · University of Utah

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Women and individuals with a cervix.
Aged 25-65 years during the study measurement period.
Qualifying visit to the participating clinic.
Overdue for cervical cancer screening.
Those aged 24-64 who have not had cervical cytology (i.e., Pap test) performed within the last three and a half (3.5) years, or those aged 30-65 who have not had cervical HPV testing (i.e., primary HPV testing or contesting for HPV with Pap test) performed within the last five and a half (5.5) years.

Exclusion

Individuals without a cervix.
Receiving hospice and/or palliative care during any part of the measurement period.
  • Clinic Level Implementation Rate1 year

    The proportion of people with a cervix who complete the test out of the number of people we were approached.